August 15, 2024Open Access

Supplementary Data 2 from Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1

View Full Paper

Ask AI

Bookmark

Abstract

Supplemental Table 2: EC50 (µm) of the drugs tested on cells dissociated from patients tumors expressing (middle column) DNAJB1::PRKACA or (right column) ATP1B1::PRKACA.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shirani et al. (2024) studied this question.

synapsesocial.com/papers/68e5c1f0b6db6435875599eb https://doi.org/10.1158/0008-5472.26710873

View Full Paper

Ask AI

Bookmark

Abstract

Supplemental Table 2: EC50 (µm) of the drugs tested on cells dissociated from patients tumors expressing (middle column) DNAJB1::PRKACA or (right column) ATP1B1::PRKACA.

Supplementary Data 2 from Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1

Abstract

Discussion

Cite This Study

Supplementary Data 2 from Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1

Abstract

Discussion

Cite This Study

Keep reading

Keep reading